Vnitr Lek 2022, 68(8):514-516 | DOI: 10.36290/vnl.2022.109

Traditional and new biomarkers of congestion in heart failure

Táňa Andreasová1, Filip Málek1, 2
1 Kardiovaskulární centrum, Nemocnice Na Homolce, Praha
2 Interní klinika FNKV a 3. LF UK Praha

The presence of pulmonary and systemic congestion is the main cause of the poor outcome of the patients with heart failure. Despite of the availability of several tools of the modern medicine, the degree of congestion is usualy difficult to evaulate. The clinical, imaging and laboratory methods are the tools, which can estimated the degree of congestion.

Keywords: congestion, biomarkers, heart failure.

Accepted: December 1, 2022; Published: December 6, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Andreasová T, Málek F. Traditional and new biomarkers of congestion in heart failure. Vnitr Lek. 2022;68(8):514-516. doi: 10.36290/vnl.2022.109.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Girerd N, Seronde MF, Coiro S et al. Integrative assessment of congestion in heart failure throughout the patient journey. JACC Heart Failure. 2018; 6(4):273-285. Go to original source... Go to PubMed...
    2. Lassus J, Gayat E, Mueller C, et al. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol. 2013;168:2186-94. Go to original source... Go to PubMed...
    3. Maddox TM, Januzzi JL, Allen LA et al. 2021 Update to the 2017 ACC Expert Consensus Decision pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction. JACC. 2021; 77(6):772-810. Go to original source... Go to PubMed...
    4. Špinar J, Málek F, Špinarová L et al. Úprava guidelines ACC pro léčbu srdečního selhání v roce 2021. Cor Vasa. 2021;62:264-270 Go to original source...
    5. Gheorghiade M, Follath F, Ponikowski P et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive. Care Medicine. Eur J Heart Fail 2010;12:423-33. Go to original source... Go to PubMed...
    6. Mentz RJ, Kjeldsen K, Rossi GP et al. Decongestion in acute heart failure. Eur J Heart Fail. 2014;16:471-82. Go to original source... Go to PubMed...
    7. Beneš J, Kotrč M, Conrad MJ, et al. Exercise dynamics of cardiac biomarkers and hemoconcentration in patients with chronic systolic heart failure. J Card Fail. 2020,26(12):1100-1105. Go to original source... Go to PubMed...
    8. Duarte K, Monnez JM, Albuisson E et al. Prognostic value of estimated plasma volume in heart failure. J Am Coll Cardiol. HF. 2015;3:886-93. Go to original source... Go to PubMed...
    9. Pitt B, Remme W, Zannad F et al. For the Eplerenone Post‑Acute Myocardial. Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-21. Go to original source... Go to PubMed...
    10. Mullens W, Abrahams Z, Francis GS et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589-96. Go to original source... Go to PubMed...
    11. Brisco MA, Coca SG, Chen J et al. Blood urea nitrogen/creatinine ratio identifies a high‑risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure. Circ Heart Fail. 2013;6:233-9. Go to original source... Go to PubMed...
    12. Shinagawa H, Inomata T, Koitabashi T et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure.Circ J. 2008;72:364-9. Go to original source... Go to PubMed...
    13. Felder L, Mund A, Parker JG. Liver Function Test in Chronic Congestive Heart Failure. Circulation 1950,2(2):286-297. Go to original source... Go to PubMed...
    14. Sarraf M, Masoumi A, Schrier RW. Cardiorenal syndrome in acute decompensated heart failure. Clin J Am Soc Nephrol. 2009;4: 2013-2026. Go to original source... Go to PubMed...
    15. Cadnapaphornchai MA, Gurevich AK, Weinberger HD, Schrier RW. Pathophysiology of sodium and water retention in heart failure. Cardiology 2001;96:122-131. Go to original source... Go to PubMed...
    16. Chaudhry SI, Wang Y, Concato J, Gill TM, Krumholz HM. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007;116:1549-1554. Go to original source... Go to PubMed...
    17. Zile MR, Bennett TD, St. John Sutton M et al.Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 2008;118:1433-1441. Go to original source... Go to PubMed...
    18. Núñez J, Miňana G, Nuňez E et al. Clinical utility of antigen carbohydrate 125 in heart failure. Heart Fail Rev. 2014;19:575-584. Go to original source... Go to PubMed...
    19. Fudim M, Felker M. Biomarkers of Congestion. Emerging Tools in the Management of Heart Failure? JACC Heart Failure. 2020,8(5):398-400. Go to original source... Go to PubMed...
    20. Núñez J, Nunez E, Sanchis J et al. Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure. Int J Cardiol. 2012;159:21-8. Go to original source... Go to PubMed...
    21. Núñez J, Llacer P, Bertomeu‑Gonzalez V et al. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE‑HF: a randomized study. J Am Coll Cardiol HF. 2016;4:833-43.
    22. Núñez J, Llacer P, Garcia‑Blas S et al. CA125- Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction. Am J Med. 2020;133:370-80.e4. Go to original source... Go to PubMed...
    23. Núñez J, Bayés‑Genís A, Revuelta‑López E et al. Clinical role of CA125 in worsening heart failure: a BIOSTAT‑CHF study subanalysis. J Am Coll Cardiol HF. 2020;8:386-97. Go to original source... Go to PubMed...
    24. Arrigo M, Truong QA, Onat D et al. Soluble CD146 is a novel marker of systemic congestion in heart failure patients: an experimental mechanistic and transcardiac clinical study. Clin Chem. 2017;63:386-393. Go to original source... Go to PubMed...
    25. Gayat E, Caillard A, Laribi S. et al. Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure. Int J Cardiol 2015;199:241-247. Go to original source... Go to PubMed...
    26. Kubena P, Arrigo M, Parenica J et al. Plasma levels of soluble CD146 reflect the severity of pulmonary congestion better than brain natriuretic peptide in acute coronary syndrome. Ann Lab Med. 2016;36:300-305. Go to original source... Go to PubMed...
    27. Peacock WF. Novel biomarkers in acute heart failure: MR‑pro‑adrenomedullin.Clin Chem Lab Med. 2014;52:1433-1435. Go to original source... Go to PubMed...
    28. Maisel A, Mueller C, Nowak RM et al. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2011;58:1057-1067 Go to original source... Go to PubMed...
    29. Willenbrock R, Langenickel T, Knecht M, et al. Regulation of cardiac adrenomedullin‑mRNA in different stages of experimental heart failure. Life Sci. 1999;65:2241-2249. Go to original source... Go to PubMed...
    30. Fudim M, Lerman JB, Page C et al. Plasma Volume Status and Its Association With In‑Hospital and Postdischarge Outcomes in Decompensated Heart Failure. Journal of Cardiac Failure. 2021;27(3):297-308. Go to original source... Go to PubMed...
    31. Tamaki S, Yamada T, Morita T et al. Comparison of the prognostic values of formulas for the estimation of plasma volume in patients admitted for acute decompensated heart failure: a prospective study. Eur Heart J Suppl. 2018, ehy565.P2820 Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.